Weng T I, Wu H Y, Kuo C W, et al. Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation[J]. Intensive Care Med,2011,37(3):533.
Masahiro Ogata, Midori Hoshi, Kumiko Shimotohno, et al. Antioxidant activity of magnolol, honokiol, and related phenolic compounds[J]. J Am Oil Chem Soc,1997,74(5):562.
[4]
Zhao C, Liu Z Q. Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA[J]. Biochemie, 2011, 93:1755.
[5]
Sun Ju Kim, Do Young Kwon, Yeong Shik Kim, et al. Peroxyl radical scavenging capacity of extracts and isolated components from selected medicinal plants[J].Arch Pharm Res, 2010,33(6):867.
[6]
Li H B, Gao J M, Ying X X, et, al. Protective effect of magnolol on TBHP-induced injury in H460 cells partially via a p53 dependent mechanism[J]. Arch Pharm Res, 2007, 30(7):850.
[7]
Saito J, Shibuya K, Nagasc H. Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice[J].Food Chem Toxicol, 2008, 46(2): 694.
[8]
Namba T, Tsunezuka M, Bae K H, et al. Studies on dental caries prevention by traditional Chinese medicine (part 1):screening of crude drug for antibacterial action against Streptococcus mutans[J]. Shoyakugaku Zasshi, 1981,35(4):295.
[9]
Bae K, Yoo B, Lee M, et al. Antimicrobial activities of hydroxybiphenyl derivatives (I);antibacterial activities and HPLC determination of magnolol and honokiol[J]. Arch Pharm Res, 1985,8(2):85.
[10]
Mori M, Aoyama M, Doi S. Antifungal constituents in the bark of Maonolia obovata Thunb[J]. Holzals Roh-und Werkstoff, 1997,55(2/4):275.
[11]
Bang K H, Kim Y K, Min B S, et al. Antifungal activity of magnolol and honokiol[J]. Arch Pharm Res, 2000,23(1):46.
[12]
Park J, Lee J, Jung E, et al. In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp.[J]. Eur J Pharmacol, 2004, 496: 189.
[13]
Lai Wah Chan, Emily L C Cheah, Constance L L Saw, et al. Antimicrobial and antioxidant activities of Cortex Magnoliae Officinalis and some other medicinal plants commonly used in South-East Asia[J]. Chin Med J, 2008,3:15.
[14]
Tsai Y C, Cheng P Y, Kung C W, et al. Beneficial effects of magnolol in a rodent model of endotoxin shock[J]. Eur J Pharm, 2010, 641(1):67.
[15]
Fried L E, Arbiser J L. Honokiol, a multifunctional antiangiogenic and antitumor agent[J]. Antioxid Redox Signal, 2009,11:1139.
[16]
chühly W, Khan S I, Fischer N H. Neolignans from north American magnolia species with cyclooxygenase 2 inhibitory activity[J]. Inflammopharmacology, 2009,17:106.
[17]
Tse A K, Wan C K, Zhu G Y, et al. Magnolol suppresses NF-κB activation and NF-κB regulated gene expression through inhibition of IkappaB kinase activation[J]. Mol Immunol, 2007,44:2647.
[18]
Lu Y C, Chen H H, Ko C H, et al. The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus[J]. Naunyn Schmiedebergs Arch Pharmacol, 2003, 368:262.
[19]
Lin Y R, Chen H H, Ko C H, et al. Effects of honokiol and magnolol on acute and inflammatory pain models in mice[J]. Life Sci, 2007, 81: 1071.
[20]
Lin Y R, Chen H H, Lin Y C, et al. Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain[J].J Biomed Sci, 2009, 16:94.
[21]
Lee S J, Park S S, Lee U S, et al. Signaling pathway for TNFalpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells[J]. Int Immunopharmacol, 2008, 8: 1821.
[22]
Lee D H, Szczepanski M J, Lee Y J. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells[J]. J Cell Biochem, 2009, 106:1113.
[23]
Chuang T C, Hsu S C, Cheng Y T, et al. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells[J]. Cancer Lett, 2011, 311: 11.
[24]
Chen L C, Liu Y C, Liang, et al. Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1[J]. J Agric Food Chem, 2009, 57: 7331.
[25]
Huang S H, Chen Y, Tung P Y, et al. Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells[J]. J Cell Biochem, 2007, 101: 1011.
[26]
Ikai T, Akao Y, Nakagawa Y, et al. Magnolol induced apoptosis is mediated via the intrinsic pathway with release of AIF from mitochondria in U937 cells[J]. Biol Pharm Bull, 2006, 29: 2498.
[27]
You Q J, Li M Q, Jiao G Q. Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells[J]. Arch Pharm Res, 2009, 32(12): 1789.
[28]
Seo J U, Kim M H, Kim H M, et al. Anticancer potential of magnolol for lung cancer treatment[J]. Arch Pharm Res, 2011, 34(4): 625.
[29]
Li H B, Yi X, Gao J M, et al. Magnolol-induced H460 cells death via autophagy but not apoptosis[J]. Arch Pharm Res, 2007, 30(12): 1566.
[30]
Jeong S I, Kim Y S, Lee M Y, et al. Regulation of contractile activity by magnolol in the rat isolated gastrointestinal tracts[J]. Pharmacol Res, 2009, 59:183.
[31]
Yang T C, Zhang S W, Sun L N, et al.Magnolol attenuates sepsis induced astrointestina1 dysmotility in rats by modulating inflammatory mediators[J].World J Gastroenterol, 2008, 14(48): 7353.
[32]
Loong C C, Chiu J H, Tiao R C, et al. Protective effect of magnolol on the small intestinal ischemia-reperfusion injury[J]. Transplant Proc, 2002, 34:2679.
[33]
Chen Y H, Lin F Y, Liu P L, et al. Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats[J]. Arch Pharm Res, 2009,32(2):221.
[34]
Chen Y H, Lin S J, Chen Y L, et al. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules[J]. Cardiovasc Hematol Disord Drug Targets, 2006,6:279.
[35]
Chen J H, Wu C C, Hsiao G, et al. Magnolol induces apoptosis in vascular smooth muscle[J]. Naunyn Schmiedeberg Arch Pharmacol,2003,368:127.
[36]
Kim H M, Bae S J, Kim D W, et, al. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells[J]. Int Immunopharmacol, 2007, 7: 1083.
[37]
Ou H C, Chou F P, Sheu W H, et al. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells[J]. Arch Toxicol, 2007, 81:421.
[38]
Liou J Y, Chen Y L, Loh S H, et al. Magnolol depresses urotensin-Ⅱ-induced cell proliferation in rat cardiac fibroblasts[J]. Clin Eex Pharmacol Physiol, 2009, 36: 711.
[39]
Qiang L Q, Wang C P, Wang F M, et al. Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism in rats[J]. Arch Pharmacal Res, 2009, 32( 9): 1281.
[40]
Xu Q, Yi L T, Pan Y, et al. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32:715.
[41]
Lin Y R, Chen H H, Ko C H, et al. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage[J]. Eur J Pharmacol, 2006, 537: 64.
[42]
Zhai H, Nakade K, Oda M, et al. Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2) [J]. Eur J Pharmacol, 2005, 516:112.
[43]
Matsui, N, Takahashi, K, Takeichi M, et al. Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice[J]. Brain Res, 2009, 1305: 108.
[44]
Choi S S, Cha B Y, Lee Y S, et al. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells[J]. Life Sci, 2009, 84: 908.
[45]
Sohn E J, Kim C S, Kim Y S, et al. Effects of magnolol (5,5\'-diallyl-2,2\'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats [J]. Life Sci, 2007, 80:468.
[46]
Kim Y S, Jung D H, Kim N H, et al. Effect of magnolol on TGF-β1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions[J]. Eur J Pharmacol, 2007, 562:12.
[47]
Chen H Y, Hung Y C, Lee E J, et al. The protective efficacy of magnolol in hind limb ischemia-reperfusion injury[J]. Phytomedicine, 2009, 16: 976.
[48]
Franck Amblard, Baskaran Govindarajan, Benjamin Lefkove, et al. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol[J]. Bioorg Med Chem Lett, 2007, 17;4428.
[49]
Han S J, Bae E A, Trinh H T, et al. Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors[J]. Biol Pharm Bull, 2007, 30:2201.
[50]
Huang B B, Fan M W, Wang S L, et al. The inhibitory effect of magnolol from Magnolia officinalis on glucosyltransferase[J]. Arch Oral Biol, 2006, 51:899.
[51]
Tanaka K, Hasegawa J, Asamitsu K, et al. Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor κB[J]. Eur J Pharmacol, 2007, 565:212.
[52]
Shih H C, Huang M S, Lee C H. Magnolol attenuates the lung injury in hypertonic saline treatment from mesenteric ischemia reperfusion through diminishing iNOS[J]. J Surg Res, 2012,175(2):305.
[53]
Wei Y J, Tsai K S, Lin L C, et al. Catechin stimulates osteogenesis by enhancing PP2A activity in human mesenchymal stem cells[J]. Osteoporos Int, 2011, 22: 1469.
